Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Ophthalmology

 

Top 5 UK for-profit ophthalmology providers

This infographic shows the top five for-profit ophthalmology providers in the UK, ordered by 2023 revenue. The revenue figures are for UK revenue exclusively. Some of the figures are HBI estimates.  
June 4, 2025

How can ophthalmology groups across the globe successfully boost growth and value creation? — in conversation with ZEISS

Demand in ophthalmology is growing, driven by an ageing population and a rise in eye-related conditions. This, coupled with exciting new technologies, personalised care solutions, and advances in cataract and refractive surgery, means national and international groups are expanding. HBI spoke with Ana Neves and Michael Achtelik from ZEISS Medical Technology for some initial insights ahead of HBI 2025 on strategies for growth and value creation for ophthalmology groups in different markets across the globe, how international operators can drive commercial and operational excellence, and what technology’s role is in driving performance.
March 20, 2025

Sanoptis gets €250m from Carlyle to fund M&A 

Pan-European German ophthalmology group Sanoptis has raised €250 million from US private equity firm Carlyle to fund its growth and expansion through “strategic acquisitions”.
March 20, 2025

Montefiore Investment’s acquisition of Demenego closes

Montefiore Investment, a French private equity firm dedicated to service SMEs and mid-market companies, announced in October plans to acquire a majority stake in Demenego, a chain of specialised optical centres in North-East Italy — and deal advisor Houlihan Lokey has now confirmed the transaction closed on 10 December.
December 19, 2024

Swiss healthcare financing reform to benefit private outpatient sector

Switzerland has voted to overhaul how its healthcare system is financed. Inpatient and outpatient care will both be financed in the same way from 2028, which should enable private outpatient clinics to compete on a more level playing field with public hospitals, particularly in specialisms which are increasingly done on an outpatient basis, such as ophthalmology.
December 5, 2024

German government’s collapse kills MVZ reform — at least for now

Germany’s cabinet coalition government has collapsed. This means a major reform launched by (soon to be former) Health Minister Karl Lauterbach which in its original form proposed effectively banning “locust” investors from buying outpatient facilities, but had subsequently been heavily watered down, will now not be passed at all. The desire to increase restrictions on private investment may live on in future governments, however.
November 18, 2024
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us